A
Arcellx Inc
NASDAQ:ACLX
Arcellx Inc
NASDAQ:ACLX
Price:
114.83
USD
0.03%
Market Closed
Market Cap:
$6.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Arcellx Inc
NASDAQ:ACLX
|
US |
|
Medicover AB
STO:MCOV B
|
SE |
|
DL E&C Co Ltd
KRX:375500
|
KR |
|
T
|
Thanh Dat Investment Development JSC
VN:DTD
|
VN |
|
Royal Gold Inc
NASDAQ:RGLD
|
US |
|
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD
|
IL |
|
Kura Sushi USA Inc
NASDAQ:KRUS
|
US |
|
LNA Sante SA
PAR:LNA
|
FR |
|
Mako Mining Corp
XTSX:MKO
|
CA |
Balance Sheet
Balance Sheet Decomposition
Arcellx Inc
Arcellx Inc
Balance Sheet Decomposition is not available for
Arcellx Inc
Arcellx Inc
Balance Sheet
Arcellx Inc
Arcellx Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
15
|
35
|
47
|
31
|
64
|
395
|
106
|
80
|
|
| Cash Equivalents |
15
|
35
|
47
|
31
|
64
|
395
|
106
|
80
|
|
| Short-Term Investments |
0
|
0
|
0
|
74
|
191
|
307
|
482
|
370
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
4
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
4
|
3
|
8
|
12
|
14
|
9
|
8
|
|
| Total Current Assets |
15
|
38
|
49
|
113
|
267
|
716
|
599
|
462
|
|
| PP&E Net |
1
|
4
|
5
|
10
|
40
|
70
|
70
|
66
|
|
| PP&E Gross |
1
|
4
|
5
|
10
|
40
|
70
|
70
|
66
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
2
|
4
|
5
|
9
|
16
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
27
|
38
|
70
|
|
| Other Long-Term Assets |
0
|
1
|
3
|
6
|
7
|
12
|
3
|
6
|
|
| Total Assets |
16
N/A
|
44
+176%
|
58
+32%
|
129
+123%
|
314
+144%
|
825
+163%
|
711
-14%
|
604
-15%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
2
|
1
|
1
|
9
|
3
|
2
|
6
|
|
| Accrued Liabilities |
1
|
1
|
5
|
13
|
15
|
26
|
64
|
43
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
33
|
39
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
51
|
59
|
56
|
|
| Total Current Liabilities |
2
|
3
|
5
|
15
|
57
|
118
|
125
|
104
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
21
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
2
|
2
|
2
|
31
|
222
|
131
|
97
|
|
| Total Liabilities |
2
N/A
|
5
+158%
|
7
+47%
|
17
+135%
|
109
+544%
|
340
+212%
|
257
-24%
|
202
-21%
|
|
| Equity | |||||||||
| Common Stock |
29
|
72
|
114
|
233
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
15
|
33
|
65
|
130
|
319
|
389
|
497
|
726
|
|
| Additional Paid In Capital |
0
|
0
|
1
|
9
|
524
|
874
|
951
|
1 127
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Equity |
14
N/A
|
39
+176%
|
51
+30%
|
112
+122%
|
205
+83%
|
485
+137%
|
455
-6%
|
402
-12%
|
|
| Total Liabilities & Equity |
16
N/A
|
44
+176%
|
58
+32%
|
129
+123%
|
314
+144%
|
825
+163%
|
711
-14%
|
604
-15%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
35
|
35
|
35
|
35
|
44
|
52
|
54
|
58
|
|
Switch to:
Switch to:
See Also
Discover More
